Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model

Distribution of influenza virus types by age using case-based global surveillance data from twenty-nine countries, 1999-2014

(2018) Saverio Caini et al.   BMC INFECTIOUS DISEASES

Literature review of the epidemiology of influenza B disease in 15 countries in the Asia-Pacific region

(2018) Lance Jennings et al.   Influenza and Other Respiratory Viruses

Advances in measuring influenza burden of disease

(2018) Vernon J. Lee et al.   Influenza and Other Respiratory Viruses

Evidence for Viral Interference and Cross-reactive Protective Immunity Between Influenza B Virus Lineages

(2018) Karen L Laurie et al.   JOURNAL OF INFECTIOUS DISEASES

Recommendations for Prevention and Control of Influenza in Children, 2017 – 2018

(2017)   PEDIATRICS

Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2–49years

(2017) Roger Baxter et al.   VACCINE

A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control

(2017) Riju Ray et al.   Human Vaccines & Immunotherapeutics

Safety of Intranasal Quadrivalent Live Attenuated Influenza Vaccine (QLAIV) in Children and Adolescents: A Pilot Prospective Cohort Study in England

(2016) Rhian McNaughton et al.   DRUG SAFETY

Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories

(2016) Larisa Rudenko et al.   VACCINE

Live attenuated influenza vaccine tetravalent: a clinical review

(2015) Allyn R Bandell et al.   Expert Review of Vaccines

Influenza B virus-specific CD8+ T-lymphocytes strongly cross-react with viruses of the opposing influenza B lineage

(2015) Carolien E. van de Sandt et al.   JOURNAL OF GENERAL VIROLOGY

Global circulation patterns of seasonal influenza viruses vary with antigenic drift

(2015) Trevor Bedford et al.   NATURE

Report on the second WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Geneva, Switzerland, 5–7 May 2014

(2015) Nancy J. Cox et al.   VACCINE

Post-licensure surveillance of quadrivalent live attenuated influenza vaccine United States, Vaccine Adverse Event Reporting System (VAERS), July 2013–June 2014

(2015) Penina Haber et al.   VACCINE

Influenza: Can we cope better with the unpredictable?

(2015) Gaël Dos Santos et al.   Human Vaccines & Immunotherapeutics

An Assessment of the Expected Cost-Effectiveness of Quadrivalent Influenza Vaccines in Ontario, Canada Using a Static Model

(2015) Ayman Chit et al.   PLoS One

Impact of Influenza B Lineage-Level Mismatch Between Trivalent Seasonal Influenza Vaccines and Circulating Viruses, 1999–2012

(2014) Terho Heikkinen et al.   CLINICAL INFECTIOUS DISEASES

Animal models for influenza virus pathogenesis, transmission, and immunology

(2014) Rajagowthamee R. Thangavel et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Key issues and challenges in estimating the impact and cost-effectiveness of quadrivalent influenza vaccination

(2014) Emma Quinn et al.   Expert Review of Pharmacoeconomics & Outcomes Research

Development of one-step real-time PCR assay for titrating trivalent live attenuated influenza vaccines

(2014) Yang Zang et al.   Human Vaccines & Immunotherapeutics

The Burden of Influenza B: A Structured Literature Review

(2013) W. Paul Glezen et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis

(2013) Andrea C Tricco et al.   BMC Medicine

Evaluation of the Humoral and Cellular Immune Responses Elicited by the Live Attenuated and Inactivated Influenza Vaccines and Their Roles in Heterologous Protection in Ferrets

(2013) Xing Cheng et al.   JOURNAL OF INFECTIOUS DISEASES

Cross-Protective Immune Responses Elicited by Live Attenuated Influenza Vaccines

(2013) Yo Han Jang et al.   YONSEI MEDICAL JOURNAL

The Coming Era of Quadrivalent Human Influenza Vaccines

(2012) Ian G. Barr et al.   DRUGS

Quadrivalent Ann Arbor strain live-attenuated influenza vaccine

(2012) Seth L Toback et al.   Expert Review of Vaccines

Immunogenicity of a quadrivalent Ann Arbor strain live attenuated influenza vaccine delivered using a blow-fill-seal device in adults: a randomized, active-controlled study*

(2012) Eric A. Sheldon et al.   Influenza and Other Respiratory Viruses

Cross-Lineage Influenza B and Heterologous Influenza A Antibody Responses in Vaccinated Mice: Immunologic Interactions and B/Yamagata Dominance

(2012) Danuta M. Skowronski et al.   PLoS One

Phylogenetic and Evolutionary History of Influenza B Viruses, which Caused a Large Epidemic in 2011–2012, Taiwan

(2012) Ji-Rong Yang et al.   PLoS One

Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine

(2012) Carrie Reed et al.   VACCINE

The rationale for quadrivalent influenza vaccines

(2012) Christopher S. Ambrose et al.   Human Vaccines & Immunotherapeutics

The ferret as a model organism to study influenza A virus infection

(2011) J. A. Belser et al.   Disease Models & Mechanisms

Protective efficacy of live-attenuated influenza vaccine (multivalent, Ann Arbor strain): a literature review addressing interference

(2011) Allyn Bandell et al.   Expert Review of Vaccines

Influenza B/Victoria Antigen Induces Strong Recall of B/Yamagata But Lower B/Victoria Response in Children Primed With Two Doses of B/Yamagata

(2011) Danuta M. Skowronski et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Comparative Analyses of Pandemic H1N1 and Seasonal H1N1, H3N2, and Influenza B Infections Depict Distinct Clinical Pictures in Ferrets

(2011) Stephen S. H. Huang et al.   PLoS One

A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults

(2011) Stan L. Block et al.   VACCINE

The need for quadrivalent vaccine against seasonal influenza

(2010) Robert B. Belshe   VACCINE

A highly attenuated recombinant human respiratory syncytial virus lacking the G protein induces long-lasting protection in cotton rats

(2010) Myra N Widjojoatmodjo et al.   Virology Journal

Animal Models for Influenza Virus Pathogenesis and Transmission

(2010) Nicole M. Bouvier et al.   Viruses-Basel

Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages

(2009) B. Camilloni et al.   VACCINE

Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity

(2009) Robert B. Belshe et al.   VACCINE

Clinical and genetic characterization of severe influenza B-associated diseases during an outbreak in Taiwan

(2008) Wen-Chen Li et al.   JOURNAL OF CLINICAL VIROLOGY

The Evolutionary Dynamics of Human Influenza B Virus

(2008) Rubing Chen et al.   JOURNAL OF MOLECULAR EVOLUTION